Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00662181 |
Recruitment Status
: Unknown
Verified April 2008 by Hvidovre University Hospital.
Recruitment status was: Not yet recruiting
First Posted
: April 21, 2008
Last Update Posted
: April 21, 2008
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
HIV Infections HIV-Associated Lipodystrophy Syndrome |
Study Type : | Observational |
Estimated Enrollment : | 46 participants |
Official Title: | Follow-up on the HIGH: Low Study - the Longterm Effect of Growth Hormone |
Study Start Date : | May 2008 |
Estimated Primary Completion Date : | October 2008 |
Estimated Study Completion Date : | January 2009 |
Group/Cohort |
---|
H, NH
HIV positive patients with and without lipodystrophy
|
- Quality of life [ Time Frame: 6 months follow-up ]
- Metabolism [ Time Frame: 6 months follow-up ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- over 18 years of age
- Participated in and completed the HIGH: low study
- informed consent signed
Exclusion Criteria:
- Patient stopped at Hvidovre Hospital, or didn't finish the HIGH: low study

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00662181
Contact: Katrine MH Andersen, stud.med. | 45-36-322-108 | katrine.harries.andersen@hvh.regionh.dk |
Denmark | |
Klinisk Forskningscenter, Hvidovre Hospital | Not yet recruiting |
Hvidovre, Denmark, 2650 | |
Contact: Katrine Andersen, Stud.med. 45-36-322-108 katrine.harries.andersen@hvh.regionh.dk | |
Principal Investigator: Ove Andersen, MD |
Principal Investigator: | Ove Andersen, MD | Klinisk Forskningcenter, Hvidovre Hospital |
Additional Information:
Responsible Party: | Forskningschef Ove Andersen, Klinisk Forskningscenter, Hvidovre Hospital |
ClinicalTrials.gov Identifier: | NCT00662181 History of Changes |
Other Study ID Numbers: |
H-B-2008-053 2008-41-2145 |
First Posted: | April 21, 2008 Key Record Dates |
Last Update Posted: | April 21, 2008 |
Last Verified: | April 2008 |
Keywords provided by Hvidovre University Hospital:
growth hormone quality of life fat redistribution |
sugar metabolism fat metabolism cytokines |
Additional relevant MeSH terms:
HIV Infections HIV-Associated Lipodystrophy Syndrome Lipodystrophy Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases |
Immunologic Deficiency Syndromes Immune System Diseases Skin Diseases, Metabolic Skin Diseases Lipid Metabolism Disorders Metabolic Diseases Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Physiological Effects of Drugs |